Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
TONMYA (CYCLOBENZAPRINE HYDROCHLORIDE) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
TONMYA
NDA
Get alerts
CYCLOBENZAPRINE HYDROCHLORIDE | N219428 | TONIX PHARMACEUTICALS INC
1 strength
4 unique patents
1 unique exclusivity
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
DMF
Approvals
Label
Products
Patent Timeline
4 unique patents, 1 exclusivity by expiration date
Active (4)
Today
Exclusivity
2027
2028
2029
2030
2031
2032
2033
2034
Today
9636408
Mar. 14, 2034
9956188
Mar. 14, 2034
10117936
Mar. 14, 2034
10864175
Mar. 14, 2034
NP
Aug. 15, 2028
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — 2.8MG
RLD
4 patents
1 exclusivity
▴
TABLET;SUBLINGUAL | Approved: Aug 15, 2025
Patents (4)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
9636408
Mar 14, 2034
—
—
Yes
—
—
9956188
Mar 14, 2034
—
—
Yes
—
—
10117936
Mar 14, 2034
—
—
Yes
—
—
10864175
Mar 14, 2034
—
—
Yes
—
—
Exclusivities (1)
Code
Date
Status
NP
Aug 15, 2028
Active